
Sign up to save your podcasts
Or


It’s no shock that percutaneous ventricular assist devices (pVADs) play an important role in improving cardiogenic shock outcomes (pun intended). In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo interviews Dr. Babar Basir, a renowned interventional cardiologist from Michigan, about advancements and protocols in managing cardiogenic shock.
---
SYNPOSIS
Dr. Babar Basir details the history and development of the cardiogenic shock program initiated at Henry Ford Hospital, its national expansion, and its impact on patient outcomes. The conversation touches on the role of advanced heart failure specialists, ongoing trials like the Door to Unload trial, and the importance of small bore mechanical circulatory support devices. Dr. Babar Basir also highlights the significance of team-based approaches and the necessity of multidisciplinary care in improving survival rates for patients suffering from cardiogenic shock.
---
TIMESTAMPS
00:00 - Introduction
03:50 - Impella in Shock: From Last-Resort to Early Use
07:30 - National Cardiogenic Shock Initiative
14:30 - Heart Failure Readmissions
17:46 - Additional Indications for Use of Impella Device
24:10 - Future Devices and Technological Advancements in the Field
27:03 - International Advancements in Shock Initiative Protocols
30:28 - Using Impella CP vs Impella 5.5
38:20 - SCAI Shock Conference and Importance of Attending
---
RESOURCES
Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo
Dr. Babar Basir:
https://www.henryford.com/physician-directory/b/basir-mir
National Cardiogenic Shock Initiative
https://www.henryford.com/cardiogenicshock
Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction (also known as “Door to Unload Trial”):
https://pubmed.ncbi.nlm.nih.gov/30586728/
Upcoming SCAI Shock Conference September 18th-20th, 2025
https://scai.org/education-and-events/events-schedule/2025-scai-shock-0
By BackTable Inc.It’s no shock that percutaneous ventricular assist devices (pVADs) play an important role in improving cardiogenic shock outcomes (pun intended). In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo interviews Dr. Babar Basir, a renowned interventional cardiologist from Michigan, about advancements and protocols in managing cardiogenic shock.
---
SYNPOSIS
Dr. Babar Basir details the history and development of the cardiogenic shock program initiated at Henry Ford Hospital, its national expansion, and its impact on patient outcomes. The conversation touches on the role of advanced heart failure specialists, ongoing trials like the Door to Unload trial, and the importance of small bore mechanical circulatory support devices. Dr. Babar Basir also highlights the significance of team-based approaches and the necessity of multidisciplinary care in improving survival rates for patients suffering from cardiogenic shock.
---
TIMESTAMPS
00:00 - Introduction
03:50 - Impella in Shock: From Last-Resort to Early Use
07:30 - National Cardiogenic Shock Initiative
14:30 - Heart Failure Readmissions
17:46 - Additional Indications for Use of Impella Device
24:10 - Future Devices and Technological Advancements in the Field
27:03 - International Advancements in Shock Initiative Protocols
30:28 - Using Impella CP vs Impella 5.5
38:20 - SCAI Shock Conference and Importance of Attending
---
RESOURCES
Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo
Dr. Babar Basir:
https://www.henryford.com/physician-directory/b/basir-mir
National Cardiogenic Shock Initiative
https://www.henryford.com/cardiogenicshock
Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction (also known as “Door to Unload Trial”):
https://pubmed.ncbi.nlm.nih.gov/30586728/
Upcoming SCAI Shock Conference September 18th-20th, 2025
https://scai.org/education-and-events/events-schedule/2025-scai-shock-0